NCT02811510

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I

• Status: Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Yale University · Academic / Other
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.

Detailed description

To characterize the acute effects of oral Dronabinol (10 mg capsule) in women relative to men and to begin probing the mechanisms that may underlie gender differences.

Conditions

• Cannabis

Interventions

Type	Name	Description
DRUG	Placebo	Placebo pill (no active cannabinoids)
DRUG	Dronabinol	10 mg capsule of Dronabinol will be administered orally.

Timeline

• Start date: 2016-06-01
• Primary completion: 2026-06-01
• Completion: 2026-12-01
• First posted: 2016-06-23
• Last updated: 2025-06-10

Locations

1 site across 1 country: United States